Follow The Filings

GENB position history

The shares of Generate Biomedicines (GENB) that ARK Investment Management LLC reported in each quarter’s 13F.

Equity, COM SHS

Shares held by quarter

New Add Reduce Exit

  1. 2026 Q1: 498,408 shares, $6.2M, 0.05% of portfolio, New
  2. 2026 Q2: 1,284,617 shares, $22M, 0.14% of portfolio, Add +157.7%
Holdings date Value % of holdings Shares Filing date All 13F holders